ビジネス
通貨単位:EUR
2023/FY
銘柄名売上高比率
Sanofi agreement 2022 - ANKET IPH62 - Recognition of license initial payment and income related to1,887.3万36.36%
Sanofi agreement 2022 - ANKET IPH67 -Recognition of license initial payment and income related to1,580万30.44%
Monalizumab agreement - AstraZeneca949.9万18.30%
Takeda agreement 2023455.3万8.77%
Sanofi agreement 2016200万3.85%
Invoicing of research and development costs (IPH5201)116.5万2.24%
Others1.1万0.02%
すべて表示
地域
通貨単位:EUR
2023/FY
銘柄名売上高比率
フランス5,190.1万100.00%
